{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Liu X"],"funding":["Training Program for High-caliber Talents of Clinical Research at Affiliated Hospitals of SHUTCM","Shanghai Famous Veteran Traditional Chinese Medicine Experts' Academic Experience Research Studio Construction Project","National Natural Science Foundation of China","Shanghai Famous Veteran Traditional Chinese Medicine Experts&apos; Academic Experience Research Studio Construction Project","Traditional Chinese Medicine Research Project of Shanghai Municipal Health Commission","Research project of Shanghai Municipal Health Commission"],"pagination":["263"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC12914991"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["26(1)"],"pubmed_abstract":["<h4>Background</h4>Increasing studies have examined the combination of traditional Chinese medicine (TCM) with Transcatheter arterial chemoembolization (TACE) in treating liver cancer. However, these results were inconsistent in immune function. Therefore, our study aimed to conduct a meta-analysis to evaluate the immune function of TCM combined with TACE in liver cancer patients.<h4>Methods</h4>Seven electronic databases were retrieved from January 1, 2014, to January 6, 2025. The Cochrane Risk of Bias 2.0 tool was used to assess the quality of all the included articles. The primary outcomes were immune-related indicators, which were measured by standard mean difference (SMD) and 95% CI. A random-effects model was used due to the inconsistent units of measurement. Subgroup analysis and se"],"journal":["BMC cancer"],"pubmed_title":["Immune effect of Traditional Chinese Medicine combined with transcatheter arterial chemoembolization in treatment of liver cancer: a meta-analysis."],"pmcid":["PMC12914991"],"funding_grant_id":["SHGZS-202223","202340139","82304932","2022QN051","TCM[2022]14"],"pubmed_authors":["Liu X","Pan X","Zhang K","Zhao S","Lv X","Sheng S","Wang Z","Wang J","Lin L"],"additional_accession":[]},"is_claimable":false,"name":"Immune effect of Traditional Chinese Medicine combined with transcatheter arterial chemoembolization in treatment of liver cancer: a meta-analysis.","description":"<h4>Background</h4>Increasing studies have examined the combination of traditional Chinese medicine (TCM) with Transcatheter arterial chemoembolization (TACE) in treating liver cancer. However, these results were inconsistent in immune function. Therefore, our study aimed to conduct a meta-analysis to evaluate the immune function of TCM combined with TACE in liver cancer patients.<h4>Methods</h4>Seven electronic databases were retrieved from January 1, 2014, to January 6, 2025. The Cochrane Risk of Bias 2.0 tool was used to assess the quality of all the included articles. The primary outcomes were immune-related indicators, which were measured by standard mean difference (SMD) and 95% CI. A random-effects model was used due to the inconsistent units of measurement. Subgroup analysis and se","dates":{"release":"2026-01-01T00:00:00Z","publication":"2026 Jan","modification":"2026-07-16T06:37:15.249Z","creation":"2026-07-09T10:39:16.833Z"},"accession":"S-EPMC12914991","cross_references":{"pubmed":["41566457"],"doi":["10.1186/s12885-026-15562-w"]}}